Xpert MTB/RIF Improves the Prognosis of Multidrug-Resistant Tuberculosis Patients Through Faster Diagnosis and Earlier Targeted Treatment: A Prospective Cohort Study

Microbial Drug Resistance, Ahead of Print.

Source: Microbial Drug Resistance - February 11, 2022 Category: Microbiology Authors: Ji-chan Shi Xianmin Wang Ri-sheng Huang Hong-ye Ning Yu-wei Cai Lian-peng Wu Sai-duo Liu Zheng-xing Wu Yue-ying Zhou Yuanliang Zheng Xian-gao Jiang Source Type: research